HC Wainwright Reaffirms Buy Rating for Agenus (NASDAQ:AGEN)

HC Wainwright reiterated their buy rating on shares of Agenus (NASDAQ:AGEN – Free Report) in a research report released on Friday morning, Benzinga reports. HC Wainwright currently has a $40.00 price objective on the biotechnology company’s stock. AGEN has been the subject of a number of other reports. B. Riley reduced their price objective on […]

Related Keywords

United States , ,Wealth Advisors ,First Command Advisory Services Inc ,Agenus Inc ,Exchange Traded Concepts ,Ables Iannone Moore Associates Inc ,Free Report ,Get Free Report ,Iannone Moore ,Command Advisory Services ,Traded Concepts ,Retrocyte Display ,Agenus Daily ,